Long-term Effects of Semaglutide on Diabetic Retinopathy in Subjects With Type 2 Diabetes
Long-term Effects of Semaglutide on Diabetic Retinopathy in Subjects With Type 2 Diabetes
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medicine). The study will be performed in people with type 2 diabetes. Participants will either get semaglutide or placebo in addition to their diabetes medicines - which treatment the participant gets is decided by chance. Participants will inject the study medicine using a pen-injector. The medicine must be injected in a skin fold in the stomach, thigh or upper arm once a week. The study will last for 5 years.
Inclusion Criteria:
Exclusion Criteria:
Münster, 48153, Germany
Saint Ingbert-Oberwürzbach, 66386, Germany
Haidari-Athens, GR-12462, Greece
Thiruvnanthapuram, Kerala 695033, India
Ansari Nagar, New Delhi 110029, New Delhi 110029, India
New Dehli, New Delhi 110029, India
Distrito Federal, México, D.F. 14080, Mexico
Zabrze, 41-800, Poland
Lodz, Łódź Voivodeship 90-302, Poland
Senhora Da Hora, Matosinhos, Matosinhos 4464-513, Portugal
Bucharest, Bucharest 020475, Romania
Moscow, 117292, Russia
Saint-Peterburg, 194044, Russia
Norfolk, NR4 7UQ, United Kingdom
Somerset, BA21 4AT, United Kingdom